India’s CDSCO Issues Order Clarifying Requirements for Clinical Trial Applications

Drug Industry Daily
Indian regulators are reminding drug investigators seeking approval for clinical trials that they must submit information on the unmet medical need and risk-benefit assessments of the proposed drug, as well as comparisons of the innovator product to existing options.

To View This Article:


Subscribe To Drug Industry Daily